Navigation Links
Maximizing Pharmaceutical Licensing Opportunities
Date:7/11/2011

os, access new technologies, and enter new geographical markets.

Cancer has emerged as the therapeutic area in which most deals are being struck. Other key therapy area targets include infectious disease, CNS disorders, metabolic/endocrine disease and auto-immune/inflammatory conditions. Rights to assets in these five therapy areas were traded in around two-thirds of all deals.

Declared financial commitments to assets licensed by the world's ten biggest pharmaceutical companies totaled more than US$78bn in the five-year period to 2010. GSK was the biggest contributor to that figure, signing deals involving up-front fees and potential milestone payments that could exceed US$19bn.

Your key questions answered

* Why do a growing number of Big Pharma CEOs favor licensing and alliance deals over M&A transactions?

* How do leading multinationals structure their licensing activities, and how are approaches changing?

* What factors lie behind the recent upturn in deal-making volumes, and will the increase be sustained?

* Which therapy areas are the subject of most licensing deals?

* Which companies top the Big Pharma licensing league in terms of deal volumes and financial commitments?

Executive Summary

Pharmaceutical licensing

Pharmaceutical licensing trends

Big Pharma licensing profiles

Future trends in pharma licensing

About the author

Disclaimer

Pharmaceutical licensing

Summary

Introduction

Mega-trends behind the pharma licensing boom

An industry in flux

Looking out, not in

Licensing

Licensing versus M&A

Goals and targets

Procedures and approaches

Pharmaceutical licensing trends

Summary

Introduction

Deal volumes

The deal-making community

Licensing targets

Deal values

Up-front payments

Milestone payments

Big Pharma li
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioInformatics, LLC New Market Report - Life Science Instruments: Maximizing Market Share
2. Maximizing the Potential of Internal and External Communications Groups
3. Maximizing the Potential of Multi-Drug Portfolios without Undermining a Legacy Brand
4. PAREXEL Expert Serves as Lead Author and Editor of Definitive Resource on Quality by Design (QbD), Aimed at Maximizing Product Quality and Speeding Treatments to Market
5. Maximizing the Potential of Multi-Drug Portfolios Without Cannibalizing from a Legacy Brand
6. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
7. Valeant Pharmaceuticals Agrees to Acquire Dermik
8. HUYA BIOSCIENCE INTERNATIONAL ENGAGES IN PARTNERSHIP WITH LIAONING (BENXI) BIO-PHARMACEUTICAL INDUSTRY BASE
9. Par Pharmaceutical Companies to Report Second Quarter 2011 Results on August 3, 2011
10. JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®, Coly-Mycin® M and Pitocin®
11. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015  Sanomedics, Inc. (OTC: SIMH, SIMHD) ("Sanomedics" ... on developing, manufacturing, and acquiring cutting-edge technology, products and ... will be exhibiting at booth # 709 at the ... (NAPNAP) taking place on March 11-13, 2015 at Caesars ... The 36 th annual NAPNAP ...
(Date:3/5/2015)... , March 5, 2015   AMC ... management solutions recognized for improving the effectiveness and ... that Robert Anazagasty and Jared ... serve as Vice President, Strategic Client Development, and ... These additions support AMC Health,s commitment to accelerating ...
(Date:3/5/2015)...  Celsion Corporation (NASDAQ: CLSN ) ... conference call to discuss year-end 2014 financial results ... for ThermoDox®, its proprietary heat-activated liposomal encapsulation of ... and TheraSilence™, in immunotherapy and RNA delivery at ... To participate in the call, interested parties may ...
Breaking Medicine Technology:Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2
... WORCESTER, Mass. and TORONTO, Nov. 21, 2011 Generex ... that its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... its study of a novel Ii-Key Hybrid-based HER-2/neu Peptide ... the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium ...
... Calif., Nov. 21, 2011  BARRX Medical Inc., a leader ... with endoscopy to remove precancerous tissue from the gastrointestinal ... agreement to be acquired by Covidien.  Covidien is a ... leader in advanced energy-based devices.  Covidien ...
Cached Medicine Technology:Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium 2Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium 3Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium 4Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium 5BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 2BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 3
(Date:3/5/2015)... Sunrise, FL (PRWEB) March 05, 2015 ... appear at this week’s Arnold Sports Festival and ... March 5-8. Metabolic Nutrition will host a display ... its all-new pre-workout E.S.P. and its highly-popular, class-leading fat ... free shaker cups, unique recipes that utilize its top-of-the-line ...
(Date:3/5/2015)... Think it’s tough to get kids to ... them to brush their teeth. That’s a finding from a ... Delta Dental(1) in conjunction with National Parenting Month in March. ... kids to brush their teeth is one of the most ... higher than getting children to eat vegetables regularly (42 percent) ...
(Date:3/5/2015)... DE (PRWEB) March 05, 2015 The ... false weight loss promises is alarming, with more and ... products without an actual prescription, making it easy for ... that simply take their money and endanger their health. ... questions before purchasing prescription online diet pills: , 1.    Where ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course ... from a variety of dental disciplines, to offer implant ... "From the onset we wanted this course to be ... to the excellence of the lecturers and the sheer ... more than satisfied our aims." , Unlike large-scale ...
(Date:3/5/2015)... Plains, NY (PRWEB) March 05, 2015 Hope ... New York Sporting Clay Shoot to be held at Beretta ... May 15, 2015. All proceeds from the event will benefit ... a sense of self, restoring the family unit, and restoring ... The event will honor our nation’s heroes through a day ...
Breaking Medicine News(10 mins):Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 2Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 3Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2
... by the National Human Genome Research Institute (NHGRI), has ... shows promise in laboratory studies for treating a fatal ... ,These drugs belong to a class of farnesyltransferase inhibitors ... myeloid leukemia, neurofibromatosis and other conditions. It could also ...
... Brisk walks or running may reduce the risk of ovarian cancer, ... may reduce the risk of some other forms of cancer. ... a 70 % reduction in the risk of development of ovarian ... colon cancer was also less frequent among those who exercised. ...
... behaviors, like over speeding, more in company of same ... sex. ,The study was published on-line edition of ... ,The findings indicate that teen risky driving increases in ... But more important, the finding should remind teens-and the ...
... from University of Pennsylvania had identified a brain chemical ... abuse. The chemical called orexin is also involved in ... ,Research showed that the activation of ... that controls many vital functions such as eating, body ...
... couples trying to conceive that is, one in every six ... a problem with conception. ,With this being the clinical ... is increasing day by day. // In spite of ... to physical, mental and psychological trauma. Anxiety of patients regarding ...
... by AUT Professor of Nutrition Elaine Rush states that ... sugar as well as caffeine contributes to obesity. // ... containing sugar, added caffeine and guarana (which also contains ... more rapidly than lemonade. "These results could have huge ...
Cached Medicine News:Health News:Brain Chemical Identified For Drug Dependent Behavior 2Health News:Will anxiety regarding fertility treatment affect the chances of conception? 2Health News:Obesity Can Be Caused By Consumption Of Energy Drinks 2
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma....
For the quantitative in vitro determination of Triglycerides in serum and plasma....
CK-MB Control...
The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum and plasma...
Medicine Products: